Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
Cancer Chemotherapy and Pharmacology|January 1, 1990
Phase II study of tallysomycin S10b in patients with advanced colorectal cancerC Nicaise, J Ajani, P Goudeau, et al.European Journal of Cancer & Clinical Oncology|February 1, 1985
Phase II study of ametantrone in a human tumor cloning assayM Rozencweig, C Sanders, W Rombaut, et al.Cancer Chemotherapy and Pharmacology|January 1, 1979
m-AMSA and PALA: two new agents in cancer chemotherapyM Rozencweig, D D Von Hoff, R L Cysyk, et al.Cancer Treatment Reports|November 1, 1979
The delta and epsilon errors in the assessment of cancer clinical trialsM J Staquet, M Rozencweig, D D Von Hoff, et al.Cancer|February 1, 1981
Clinical trials with the hexitol derivatives in the U.SD F Chiuten, M Rozencweig, D D Von Hoff, et al.Cancer|July 1, 1977
VM 26 and VP 16-213: a comparative analysisM Rozencweig, D D Von Hoff, J E Henney, et al.European Journal of Cancer & Clinical Oncology|April 1, 1984
Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungR A Joss, H H Hansen, M Hansen, et al.Archiv Fur Geschwulstforschung|January 1, 1978
Current trends and prospects in surgical adjuvant trialsM Rozencweig, D D von Hoff, A C Louie, et al.Cancer|March 1, 1978
The use of peritoneoscopy in the detection of liver metastasesH Bleiberg, M Rozencweig, M Mathieu, et al.European Journal of Cancer & Clinical Oncology|August 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative GroupU R Kleeberg, J H Mulder, P Rümke, et al.Pageof 13